A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
Condition(s):GlioblastomaLast Updated:February 16, 2024Completed
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:February 16, 2024Completed
Condition(s):HyperalgesiaLast Updated:April 20, 2012Completed
Condition(s):Acute Pain Due to TraumaLast Updated:October 31, 2012Completed
Condition(s):Carcinoma, Renal CellLast Updated:October 19, 2020Completed
Condition(s):Carcinoma, Renal CellLast Updated:October 19, 2020Completed
Condition(s):Anesthesia, IntravenousLast Updated:May 28, 2020Completed
Condition(s):Pneumococcal InfectionLast Updated:October 5, 2016Completed
Condition(s):Healthy VolunteersLast Updated:October 14, 2015Completed
Condition(s):Advanced Unresectable Pancreatic CancerLast Updated:May 19, 2008Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.